GLP-1 dosing chart: how the eight medicines start, step up and settle
The short answer
The GLP-1 dosing chart on this page lists every strength of the eight medicines, with each label's schedule in order. Every FDA-approved GLP-1 medicine starts at a low dose and steps up on a schedule written in its label. The weekly injections (Zepbound, Mounjaro, Wegovy, Ozempic, Trulicity) move up after at least 4 weeks per step, the daily tablets after 30 days, and Saxenda each week.
On this page
- How does GLP-1 dosing work?
- What is the starting dose of each GLP-1?
- How long do you stay on each dose?
- What is the maintenance dose of each GLP-1?
- What is the maximum dose?
- Weekly injection, daily tablet or daily injection: how each is taken
- Do medicines with the same molecule share a dose?
- What if you miss a dose?
- Can you stay on a lower dose?
- Dosing and cost
- Dosing mistakes to avoid
- Who decides your dose?
- Frequently asked questions
- Sources
Every strength of every GLP-1 medicine
| Medicine | Form | Taken | Label schedule (mg) | Other strengths | Doses per fill |
|---|---|---|---|---|---|
| Zepbound | KwikPen (multi-dose, 4 weekly doses) | weekly | 2.5 → 5 → 7.5 → 10 → 12.5 → 15 | Not listed | 4 |
| Zepbound | Multi-dose vial (4 weekly doses) | weekly | 2.5 → 5 → 7.5 → 10 → 12.5 → 15 | Not listed | 4 |
| Zepbound | Single-dose pen | weekly | 2.5 → 5 → 7.5 → 10 → 12.5 → 15 | Not listed | 4 |
| Zepbound | Single-dose vial | weekly | 2.5 → 5 → 7.5 → 10 → 12.5 → 15 | Not listed | 4 |
| Mounjaro | KwikPen (multi-dose, 4 weekly doses) | weekly | 2.5 → 5 → 7.5 → 10 → 12.5 → 15 | Not listed | 4 |
| Mounjaro | Multi-dose vial (4 weekly doses) | weekly | 2.5 → 5 → 7.5 → 10 → 12.5 → 15 | Not listed | 4 |
| Mounjaro | Single-dose pen | weekly | 2.5 → 5 → 7.5 → 10 → 12.5 → 15 | Not listed | 4 |
| Mounjaro | Single-dose vial | weekly | 2.5 → 5 → 7.5 → 10 → 12.5 → 15 | Not listed | 1 |
| Wegovy | Single-dose pen (7.2 mg pen is branded WEGOVY HD) | weekly | 0.25 → 0.5 → 1 → 1.7 → 2.4 → 7.2 | Not listed | 4 |
| Wegovy | Tablet (once daily) | daily | 1.5 → 4 → 9 → 25 | Not listed | 30 |
| Ozempic | Multi-dose single-patient-use pen (4 weekly doses per pen at the maintenance dose; the 2 mg/3 mL pen delivers 4 doses of 0.25 mg plus 2 doses of 0.5 mg, or 4 doses of 0.5 mg) | weekly | 0.25 → 0.5 → 1 → 2 | Not listed | 4 |
| Ozempic | Tablet (once daily; shares a label with Rybelsus, not substitutable mg-to-mg) | daily | 1.5 → 4 → 9 | Not listed | 30 |
| Foundayo | Tablet (once daily) | daily | 0.8 → 2.5 → 5.5 → 9 → 14.5 → 17.2 | Not listed | 30 |
| Rybelsus | Tablet (once daily) | daily | 3 → 7 → 14 | Not listed | 30 |
| Saxenda | Multi-dose single-patient-use pen, 18 mg per 3 mL pen (6 daily doses of 3 mg per pen; sold in cartons of 3 or 5 pens) | daily | 0.6 → 1.2 → 1.8 → 2.4 → 3 | Not listed | 30 |
| Trulicity | Single-dose pen | weekly | 0.75 → 1.5 → 3 → 4.5 | Not listed | 4 |
GLP-1 dosing follows one pattern across all eight medicines we track: a low starting dose, a series of step-ups with a minimum time at each one, and a dose where treatment settles. The details differ by label, and the differences matter. A weekly pen, a daily tablet and a daily pen each run on their own clock, and two brands that share a molecule do not share a schedule.
This guide explains how the labels set that pattern out. The chart above lists every strength of every form, with the label’s schedule in order. Everything here comes from the prescribing information on DailyMed, quoted in our dose records and in the sources below. It describes what the labels say. It does not tell you what dose to take, which is a decision for your prescriber.
How does GLP-1 dosing work?
You start low and step up. No label on this list starts a patient at the dose they are expected to stay on, with one partial exception: Trulicity’s starting dose of 0.75 mg may simply be continued.
The labels explain why. The Wegovy label says to follow its dosage escalation table “to reduce the risk of gastrointestinal adverse reactions.” The same reasoning appears when the Foundayo, Wegovy and Saxenda labels describe restarting after a gap: each says to begin again lower for that reason.
Three terms are worth separating:
- Starting dose. The first dose in the label’s schedule. For several medicines the label says outright that it is for initiation only. Zepbound 2.5 mg “is not approved as a maintenance dosage.” The Rybelsus 3 mg and Ozempic tablet 1.5 mg starting doses are described as not effective for glycemic control.
- Escalation steps. The doses between the start and the maintenance dose, each with a minimum time before the next increase.
- Maintenance dose. The dose, or range of doses, the label recommends for ongoing treatment.
The process of stepping up is called titration. Our titration schedules page sets out each medicine’s steps in order, and the titration schedule tool turns a start date into calendar dates.
What is the starting dose of each GLP-1?
Each label names one starting dose for adults:
- Zepbound (tirzepatide, weekly injection): 2.5 mg once weekly for 4 weeks, for all approved uses.
- Mounjaro (tirzepatide, weekly injection): 2.5 mg once weekly.
- Foundayo (orforglipron, daily tablet): 0.8 mg once daily.
- Trulicity (dulaglutide, weekly injection): 0.75 mg once weekly.
- Wegovy (semaglutide): 0.25 mg once weekly for the injection, or 1.5 mg once daily for the tablets.
- Ozempic (semaglutide): 0.25 mg once weekly for the injection, or 1.5 mg once daily for Ozempic tablets.
- Rybelsus (semaglutide, daily tablet): 3 mg once daily.
- Saxenda (liraglutide, daily injection): 0.6 mg once daily for one week.
A starting dose is not a statement about strength relative to another medicine. The milligram figures are specific to each product and cannot be compared across them.
How long do you stay on each dose?
The labels set a minimum, and it falls into three groups.
Weekly injections: at least 4 weeks per step. Zepbound moves from 2.5 mg to 5 mg after 4 weeks, and then “may be increased in 2.5 mg increments, after at least 4 weeks on the current dose.” Mounjaro uses the same increments and the same minimum. Ozempic injection is started at 0.25 mg for 4 weeks, then increased to 0.5 mg, with later increases after at least 4 weeks. Trulicity may be increased after 4 weeks, then in 1.5 mg increments after at least 4 weeks on the current dosage. Wegovy injection is different in form: its label gives a fixed table, with each of the four escalation doses assigned to a 4-week block.
Daily tablets: 30 days per step. Foundayo requires at least 30 days at 0.8 mg and at least 30 days at 2.5 mg, then allows later increases after at least 30 days on the current dosage. Wegovy tablets, Ozempic tablets and Rybelsus are all scheduled in 30-day blocks.
Saxenda: one week per step. The daily liraglutide pen steps up weekly, reaching 3 mg from week 5.
A minimum is the earliest point a step can happen, not a deadline. Our page on when to increase your dose goes through what each label says about waiting longer.
What is the maintenance dose of each GLP-1?
This is where the labels diverge most, because it depends on what the medicine is approved to treat.
Weight-management labels name specific maintenance doses.
- Zepbound: 5 mg, 10 mg or 15 mg once weekly for weight reduction and long-term maintenance. For obstructive sleep apnea the label names 10 mg or 15 mg. The 7.5 mg and 12.5 mg strengths are steps between them.
- Wegovy injection: 2.4 mg once weekly is the usual recommended maintenance dosage. For weight reduction in adults the label gives the maintenance dosage as either 1.7 mg or 2.4 mg, with 2.4 mg recommended.
- Wegovy tablets: 25 mg once daily.
- Saxenda: 3 mg daily for adults. The label says lower dosages are for titration only.
- Foundayo: the label requires the first two steps, to 5.5 mg. Beyond that, the dosage “may be increased to the next dosage level (9 mg, 14.5 mg, or 17.2 mg once daily)” based on treatment response and tolerability.
Diabetes labels tie increases to glycemic control. Mounjaro, Trulicity, Ozempic and Rybelsus do not march every patient to the top. Mounjaro’s label says to increase “if additional glycemic control is needed.” Trulicity’s and Ozempic’s use the same condition. For Rybelsus and Ozempic tablets, the second dose (7 mg and 4 mg) is continued from day 61 unless additional glycemic control is needed, in which case the label moves to 14 mg and 9 mg.
One specific instruction sits in the Ozempic injection label: for type 2 diabetes with chronic kidney disease, the dose is increased to 1 mg after at least 4 weeks on 0.5 mg, and 1 mg is the maintenance dosage for that use.
What is the maximum dose?
Each label states a ceiling:
- Zepbound: 15 mg once weekly for all uses.
- Mounjaro: 15 mg once weekly in adults, and 10 mg once weekly in pediatric patients.
- Foundayo: 17.2 mg once daily.
- Trulicity: 4.5 mg once weekly in adults.
- Wegovy injection: 7.2 mg once weekly, for weight reduction in adults only. For the label’s other uses, 2.4 mg is the maintenance dosage.
- Wegovy tablets: 25 mg once daily.
- Ozempic injection: 2 mg once weekly.
- Ozempic tablets: 9 mg once daily. Rybelsus: 14 mg once daily.
- Saxenda: 3 mg once daily.
The full list, with the strengths each form is actually supplied in, is on the dose chart page.
Weekly injection, daily tablet or daily injection: how each is taken
The dosing interval changes more than the calendar. It changes the rules around food and timing.
Weekly injections. Zepbound and Mounjaro are given once weekly at any time of day, with or without meals. Trulicity is the same, with or without food. The Wegovy and Ozempic labels add “on the same day each week.” For Zepbound, the label also asks prescribers to tell you which presentation you will receive (vial, single-dose pen or KwikPen) and make sure you are trained for that one, because how you measure a dose depends on the device.
Daily semaglutide tablets. Wegovy tablets, Ozempic tablets and Rybelsus share strict instructions: once daily in the morning, on an empty stomach, with up to 4 ounces of water and no other liquid, then a wait of at least 30 minutes before eating, drinking or taking other oral medicines.
Foundayo. Also a daily tablet, but the label says to take it once daily with or without food.
Saxenda. Injected once daily at any time of day, without regard to the timing of meals.
If you are weighing forms against each other, the pen vs vial vs pill comparer shows cost per fill, and the supply tracker shows how long a fill lasts at your dose.
Do medicines with the same molecule share a dose?
No. Two molecules appear under more than one brand, and each brand has its own label.
- Tirzepatide is in Zepbound and Mounjaro. The strengths and the 2.5 mg increments match, but the labels differ in what the dose is for. Zepbound names maintenance doses for weight reduction and sleep apnea. Mounjaro increases only when more glycemic control is needed.
- Semaglutide is in Wegovy, Ozempic and Rybelsus. The weekly injections start at the same 0.25 mg and then separate. The three tablets carry different strengths, and the label states that Rybelsus and Ozempic tablets “are not substitutable on a mg-to-mg basis.”
- Liraglutide is in Saxenda, the only liraglutide product we track.
We never convert a dose from one medicine to another, and no label we hold supplies a conversion table between different medicines. Where a label does describe a specific switch, the switching planner quotes it.
What if you miss a dose?
Every label has a rule, and no two brands’ rules are quite the same.
- Zepbound and Mounjaro: take the missed dose as soon as possible within 4 days (96 hours). After that, skip it.
- Ozempic injection: the same idea with a window of 5 days.
- Trulicity: take it if at least 3 days (72 hours) remain until the next scheduled dose.
- Wegovy injection: take it if the next scheduled dose is more than 2 days away.
- Wegovy tablets, Ozempic tablets and Rybelsus: skip the missed tablet and take the next one the following day.
- Foundayo: take the missed tablet as soon as possible, without doubling up the next dose.
- Saxenda: resume with the next scheduled dose, with no extra dose to make up.
Longer gaps trigger a second kind of rule. After 2 or more consecutive missed Wegovy injections, or 7 or more consecutive missed Foundayo tablets, the label says to reinitiate dosage escalation at a lower dosage. After more than 3 days without Saxenda, the label says to restart at 0.6 mg daily and follow the escalation schedule again.
The missed dose rules page quotes each label, and the missed dose tool applies the rule for your medicine to your own dates.
Can you stay on a lower dose?
Some labels say so directly, and some are silent.
The Wegovy injection label says that if a dose is not tolerated, a delay of 4 weeks before the next increase can be considered. Saxenda’s label allows a delay of about one additional week. Foundayo’s optional steps depend on tolerability by the label’s own wording. Zepbound’s label offers three maintenance doses for weight reduction, so 5 mg and 10 mg are destinations as well as steps.
For Zepbound, Mounjaro, Trulicity or Ozempic, stepping back down is a conversation for your prescriber. The detail, label by label, is on when to increase your dose.
Dosing and cost
Dose and price are linked for some medicines and not others. Self-pay programs often price the lowest strengths below the rest, so moving up a step can change what you pay per fill. Each drug’s dose pages show the price at that strength, and the cost calculator prices a full path from the starting dose to a target dose. For the wider picture, see our GLP-1 cost guide.
Dosing mistakes to avoid
Measuring is where dosing goes wrong most easily, especially when a dose is drawn from a vial with a syringe rather than delivered by a prefilled pen. The dosing errors explainer covers what the FDA safety sources say about units, milliliters and milligrams. Two label rules are simple enough to state here. The Wegovy tablet, Rybelsus and Foundayo labels say not to take more than one tablet per day. And the missed-dose rules that say “skip” mean exactly that: none of the labels describes taking a double dose to catch up.
Who decides your dose?
Your prescriber. The label sets the starting dose, the minimum time at each step and the maximum. Within those limits, the pace and the stopping point depend on how you respond and what you tolerate, and on which approved use the medicine was prescribed for. Take questions about your own schedule to your prescriber or pharmacist. Use this guide to know what the label says before you ask.
Frequently asked questions
What is the starting dose of a GLP-1?
It depends on the medicine. The labels start Zepbound and Mounjaro at 2.5 mg once weekly, Wegovy injection and Ozempic injection at 0.25 mg once weekly, Trulicity at 0.75 mg once weekly, Foundayo at 0.8 mg once daily, Wegovy tablets and Ozempic tablets at 1.5 mg once daily, Rybelsus at 3 mg once daily and Saxenda at 0.6 mg once daily.
How often do you increase a GLP-1 dose?
The labels set a minimum time at each step. For the weekly injections it is 4 weeks. For Foundayo, Wegovy tablets, Ozempic tablets and Rybelsus it is 30 days. Saxenda is the exception, with a step each week for the first four weeks. Several labels make later steps optional, so the minimum is the earliest a step can happen, and your prescriber decides whether it does.
What is the highest dose of each GLP-1?
Per the labels: Zepbound 15 mg once weekly, Mounjaro 15 mg once weekly in adults, Wegovy injection 7.2 mg once weekly for adult weight reduction only, Ozempic injection 2 mg once weekly, Trulicity 4.5 mg once weekly in adults, Foundayo 17.2 mg once daily, Wegovy tablets 25 mg once daily, Rybelsus 14 mg once daily and Saxenda 3 mg once daily.
What is a maintenance dose?
It is the dose a label recommends for continued treatment after the step-up period. Some labels name one, such as 2.4 mg for Wegovy injection or 3 mg for adults on Saxenda. The Zepbound label names three for weight reduction: 5 mg, 10 mg or 15 mg. The diabetes labels, such as Mounjaro and Trulicity, tie further increases to whether more glycemic control is needed.
Why do GLP-1 medicines start at a low dose?
The labels give the reason. The Wegovy label says to follow its dosage escalation table to reduce the risk of gastrointestinal adverse reactions. The Foundayo, Wegovy and Saxenda labels use the same reasoning for restarting at a lower dose after a longer gap. Some starting doses, such as Zepbound 2.5 mg, are for treatment initiation only and are not approved as maintenance doses.
Can I convert my dose from one GLP-1 to another?
No label we hold gives a conversion between different medicines, and we do not offer one. Even two semaglutide tablets differ: the label says Rybelsus and Ozempic tablets are not substitutable on a mg-to-mg basis. A change of medicine is a new prescription, and the starting dose is your prescriber's decision. Our switching planner shows what each label does say.
What happens if I miss a dose of a GLP-1?
Each label has its own rule. Zepbound and Mounjaro allow a late dose within 4 days of the missed dose, Ozempic injection within 5 days. Wegovy injection and Trulicity count the time left until the next dose instead. For Wegovy tablets, Ozempic tablets and Rybelsus the label says to skip the missed tablet. The missed-dose page lists every rule.
Do I have to go up to the highest dose?
The labels do not all require it. Zepbound lists 5 mg and 10 mg as maintenance doses alongside 15 mg. Mounjaro, Trulicity and Ozempic increase only if additional glycemic control is needed. Foundayo makes steps above 5.5 mg depend on treatment response and tolerability. Wegovy 7.2 mg is optional. Where you settle is a decision for your prescriber.
Is the Ozempic dose the same as the Wegovy dose?
No. Both contain semaglutide, but each has its own label, approved uses and schedule. Ozempic injection steps from 0.25 mg to 0.5 mg, 1 mg and a maximum of 2 mg once weekly. Wegovy injection steps from 0.25 mg through 0.5 mg, 1 mg and 1.7 mg to 2.4 mg, with an optional 7.2 mg for adult weight reduction.
What is the GLP-1 dosage for weight loss?
It depends on the medicine. The weight-management labels name specific maintenance doses: Zepbound 5 mg, 10 mg or 15 mg once weekly, Wegovy injection 2.4 mg once weekly with 1.7 mg also listed for adults, Wegovy tablets 25 mg once daily and Saxenda 3 mg daily for adults. Foundayo's label requires steps to 5.5 mg and makes higher doses depend on treatment response and tolerability.
Sources (23)
- 1.FDA label (DailyMed): Zepbound prescribing information, section 2.1
“The 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage.”
- 2.FDA label (DailyMed): Zepbound prescribing information, section 2.2
“The recommended maintenance dosage is 5 mg, 10 mg, or 15 mg, injected subcutaneously once weekly.”
- 3.FDA label (DailyMed): Zepbound prescribing information, section 2.4
“Administer ZEPBOUND once weekly at any time of day, with or without meals.”
- 4.FDA label (DailyMed): Zepbound prescribing information, section 2.4
“Inform patients and their caregiver(s) which ZEPBOUND presentation (e.g., vial, prefilled single-dose pen, single-patient-use KwikPen) they will receive and ensure they receive training appropriate for that specific presentation. If the prescribed ZEPBOUND presentation changes, ensure patients and caregivers receive appropriate training and instruct them to consult the Instructions for Use for the newly prescribed presentation.”
- 5.FDA label (DailyMed): Mounjaro prescribing information, section 2.2
“Administer MOUNJARO once weekly, any time of day, with or without meals.”
- 6.FDA label (DailyMed): Foundayo prescribing information, section 2.1
“Take FOUNDAYO orally once daily, with or without food.”
- 7.FDA label (DailyMed): Foundayo prescribing information, section 2.1
“The starting dosage is 0.8 mg orally once daily. After at least 30 days on the 0.8 mg dosage, increase the dosage to 2.5 mg once daily.”
- 8.FDA label (DailyMed): Foundayo prescribing information, section 2.1
“The maximum dosage of FOUNDAYO is 17.2 mg once daily.”
- 9.FDA label (DailyMed): Foundayo prescribing information, section 2.3
“If 7 or more consecutive doses are missed, reinitiate dosage escalation at a lower dosage to reduce the risk of gastrointestinal adverse reactions [see Dosage and Administration (2.1), Warnings and Precautions (5.3), Adverse Reactions (6)].”
- 10.FDA label (DailyMed): Trulicity prescribing information, section 2.4
“Administer TRULICITY once weekly, any time of day, with or without food.”
- 11.FDA label (DailyMed): Trulicity prescribing information, section 2.1
“The maximum recommended dosage is 4.5 mg injected subcutaneously once weekly.”
- 12.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Administer WEGOVY injection once weekly, on the same day each week, at any time of day, with or without meals.”
- 13.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Take one WEGOVY tablet orally once daily on an empty stomach in the morning with water (up to 4 ounces). Do not take WEGOVY tablets with other liquids besides water”
- 14.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“After taking a WEGOVY tablet, wait at least 30 minutes before eating food, drinking beverages or taking other oral medications”
- 15.FDA label (DailyMed): Ozempic prescribing information, section 2.1
“Administer OZEMPIC once weekly, on the same day each week, at any time of the day, with or without meals.”
- 16.FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.1
“Take one RYBELSUS or OZEMPIC tablet orally once daily on an empty stomach in the morning with water (up to 4 ounces of water). Do not take RYBELSUS or OZEMPIC tablets with other liquids besides water”
- 17.FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.1
“RYBELSUS and OZEMPIC tablets are not substitutable on a mg-to-mg basis.”
- 18.FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.1
“After taking RYBELSUS or OZEMPIC tablets, wait at least 30 minutes before eating food, drinking beverages or taking other oral medications”
- 19.FDA label (DailyMed): Rybelsus and Ozempic tablets prescribing information, section 2.1
“Do not take more than one tablet per day.”
- 20.FDA label (DailyMed): Wegovy prescribing information, section 2.1
“Do not take more than one tablet per day.”
- 21.FDA label (DailyMed): Foundayo prescribing information, section 2.1
“Do not take more than one tablet per day.”
- 22.FDA label (DailyMed): Saxenda prescribing information, section 2.1
“Inject SAXENDA subcutaneously once daily at any time of day, without regard to the timing of meals.”
- 23.FDA label (DailyMed): Saxenda prescribing information, section 2.1
“If more than 3 days have elapsed since the last SAXENDA dosage, reinitiate SAXENDA at 0.6 mg daily and follow the dosage escalation schedule in Table 1, to reduce the risk of gastrointestinal adverse reactions associated with reinitiation of treatment.”
Related pages
- Tirzepatide dosage chart and semaglutide dosing: every strength of every GLP-1
- Zepbound dose schedule and every other GLP-1 titration schedule, week by week
- Missed dose of Ozempic, Zepbound or Wegovy: the label rule for every GLP-1
- When to increase your Mounjaro, Zepbound or Wegovy dose, and when the label says to wait
- What is Zepbound? Uses, cost, doses and side effects
- What is Wegovy? Uses, doses, pill and pen, and cost
